|
|
|
|
| LEADER |
04876nma a2201453 u 4500 |
| 001 |
EB002157901 |
| 003 |
EBX01000000000000001296016 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230515 ||| eng |
| 020 |
|
|
|a 9783036561264
|
| 020 |
|
|
|a books978-3-0365-6641-2
|
| 020 |
|
|
|a 9783036566412
|
| 100 |
1 |
|
|a Brzeziński, Marek
|
| 245 |
0 |
0 |
|a Polylactide-Based Materials: Synthesis and Biomedical Applications
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (376 p.)
|
| 653 |
|
|
|a polymer
|
| 653 |
|
|
|a crosslinking
|
| 653 |
|
|
|a biodegradation
|
| 653 |
|
|
|a crystallization
|
| 653 |
|
|
|a soft tissues regeneration
|
| 653 |
|
|
|a plasticization
|
| 653 |
|
|
|a polylactide-based materials
|
| 653 |
|
|
|a impedance measurements
|
| 653 |
|
|
|a composites
|
| 653 |
|
|
|a paclitaxel resistance
|
| 653 |
|
|
|a drug delivery system
|
| 653 |
|
|
|a biodegradable materials
|
| 653 |
|
|
|a MWCNT
|
| 653 |
|
|
|a flame retardancy
|
| 653 |
|
|
|a gamma rays
|
| 653 |
|
|
|a zirconium ceramic
|
| 653 |
|
|
|a poly(ethylene glycol)
|
| 653 |
|
|
|a poly(lactic acid)
|
| 653 |
|
|
|a stereocomplex
|
| 653 |
|
|
|a star poly(L-lactide)
|
| 653 |
|
|
|a PLLA
|
| 653 |
|
|
|a diclofenac
|
| 653 |
|
|
|a sesbania gum
|
| 653 |
|
|
|a ammonium polyphosphate
|
| 653 |
|
|
|a Research & information: general / bicssc
|
| 653 |
|
|
|a polylactide nonwovens
|
| 653 |
|
|
|a Leishmania major
|
| 653 |
|
|
|a Biology, life sciences / bicssc
|
| 653 |
|
|
|a electrospinning
|
| 653 |
|
|
|a polyesters
|
| 653 |
|
|
|a polymer blends
|
| 653 |
|
|
|a PCL
|
| 653 |
|
|
|a cochlear implant
|
| 653 |
|
|
|a controlled release
|
| 653 |
|
|
|a lung cancer
|
| 653 |
|
|
|a PLA nanoparticles
|
| 653 |
|
|
|a nanoparticles
|
| 653 |
|
|
|a anticancer agent
|
| 653 |
|
|
|a biomaterial
|
| 653 |
|
|
|a irradiation
|
| 653 |
|
|
|a lesion swelling
|
| 653 |
|
|
|a reinforced fibers
|
| 653 |
|
|
|a recombinant histone H2B
|
| 653 |
|
|
|a shear-induced crystallization
|
| 653 |
|
|
|a electron-beam
|
| 653 |
|
|
|a drug delivery
|
| 653 |
|
|
|a drug delivery systems
|
| 653 |
|
|
|a biocompatibility
|
| 653 |
|
|
|a biomedical and environmental applications
|
| 653 |
|
|
|a guide tissue engineering
|
| 653 |
|
|
|a linear ladder-like poly(silsesquioxane)
|
| 653 |
|
|
|a PHBV
|
| 653 |
|
|
|a poly(lactide)
|
| 653 |
|
|
|a copolymers
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a vaccine adjuvant
|
| 653 |
|
|
|a glass fibres
|
| 653 |
|
|
|a biomedical applications
|
| 653 |
|
|
|a composite scaffold
|
| 653 |
|
|
|a polylactic acid (PLA) nanofibers
|
| 653 |
|
|
|a supramolecular interactions
|
| 653 |
|
|
|a self-assembly
|
| 653 |
|
|
|a spiral ganglion neuron
|
| 653 |
|
|
|a silylated PLA
|
| 653 |
|
|
|a scanning electron microscopy
|
| 653 |
|
|
|a photo-crosslinking
|
| 653 |
|
|
|a crystallinity
|
| 653 |
|
|
|a bone regeneration
|
| 653 |
|
|
|a PLA-based materials
|
| 653 |
|
|
|a polyester biomaterials
|
| 653 |
|
|
|a starch
|
| 653 |
|
|
|a hybrid network
|
| 653 |
|
|
|a PLLA coating
|
| 653 |
|
|
|a biodegradable polymers
|
| 653 |
|
|
|a chemical modification
|
| 653 |
|
|
|a parasite' challenge
|
| 653 |
|
|
|a block copolymers
|
| 653 |
|
|
|a metastasis
|
| 653 |
|
|
|a fibrillar nuclei
|
| 653 |
|
|
|a cyclodextrin
|
| 653 |
|
|
|a functionalized polymers
|
| 653 |
|
|
|a poly(L-lactide)
|
| 653 |
|
|
|a dual drug delivery
|
| 653 |
|
|
|a crosslinking in situ
|
| 653 |
|
|
|a biomaterials
|
| 653 |
|
|
|a mechanical properties
|
| 653 |
|
|
|a graft copolymers
|
| 653 |
|
|
|a anoikis
|
| 653 |
|
|
|a polylactide
|
| 653 |
|
|
|a polylactic acid
|
| 653 |
|
|
|a compatibilization
|
| 653 |
|
|
|a reactive blending
|
| 700 |
1 |
|
|a Baśko, Małgorzata
|
| 700 |
1 |
|
|a Brzeziński, Marek
|
| 700 |
1 |
|
|a Baśko, Małgorzata
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-6641-2
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/6817
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/98061
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 363
|
| 082 |
0 |
|
|a 000
|
| 082 |
0 |
|
|a 580
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 620
|
| 520 |
|
|
|a This reprint focuses on PLA-based materials and the modification of their properties for biomedical applications. Special emphasis is placed on the supramolecular strategies that lead to unique structures in the micro- or nanoscale. The development and testing of novel biomaterials as drug delivery carriers, implants, or tissue engineering scaffolds are of particular interest. Special attention is given to understanding the structure-properties relationship, since this allows for the development of the most effective biocompatible materials.
|